Cumberland Pharmaceuticals Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Cumberland Pharmaceuticals Inc (CPIX) has a 3-month relative strength percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 82. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.3%, relative volume 1.28×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 97, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
CPIX is in a stage 2 uptrend, week 8. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 33.6% / 78.4%.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CPIX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $893K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $893K |
| VXFVanguard Extended Market ETF | 0.00% | $283K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CPIX Jan avg: 6.53% median: 5.73% win: 50% σ: 13.68% n: 4 2022-04-12 → 2026-05-29 | CPIX Feb avg: 33.38% median: 16.80% win: 75% σ: 57.70% n: 4 2022-04-12 → 2026-05-29 | CPIX Mar avg: -20.81% median: -18.17% win: 0% σ: 9.41% n: 4 2022-04-12 → 2026-05-29 | CPIX Apr avg: 2.74% median: -4.76% win: 40% σ: 18.21% n: 5 2022-04-12 → 2026-05-29 | CPIX May avg: 5.01% median: -5.85% win: 40% σ: 23.89% n: 5 2022-04-12 → 2026-05-29 | CPIX Jun avg: -9.62% median: -4.71% win: 25% σ: 16.03% n: 4 2022-04-12 → 2026-05-29 (current) | CPIX Jul avg: 2.31% median: 3.19% win: 75% σ: 6.59% n: 4 2022-04-12 → 2026-05-29 | CPIX Aug avg: 1.91% median: 2.34% win: 75% σ: 5.88% n: 4 2022-04-12 → 2026-05-29 | CPIX Sep avg: 0.33% median: -1.32% win: 50% σ: 10.91% n: 4 2022-04-12 → 2026-05-29 | CPIX Oct avg: -2.46% median: -1.05% win: 50% σ: 7.67% n: 4 2022-04-12 → 2026-05-29 | CPIX Nov avg: -6.08% median: -12.45% win: 25% σ: 21.82% n: 4 2022-04-12 → 2026-05-29 | CPIX Dec avg: 38.44% median: 39.27% win: 75% σ: 39.87% n: 4 2022-04-12 → 2026-05-29 |